202 related articles for article (PubMed ID: 24892976)
1. Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.
Chen Z; Zhang P; Cheetham AG; Moon JH; Moxley JW; Lin YA; Cui H
J Control Release; 2014 Oct; 191():123-30. PubMed ID: 24892976
[TBL] [Abstract][Full Text] [Related]
2. pH-Sensitive nanoparticles as smart carriers for selective intracellular drug delivery to tumor.
Li XX; Chen J; Shen JM; Zhuang R; Zhang SQ; Zhu ZY; Ma JB
Int J Pharm; 2018 Jul; 545(1-2):274-285. PubMed ID: 29733971
[TBL] [Abstract][Full Text] [Related]
3. Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment.
Duong HH; Yung LY
Int J Pharm; 2013 Sep; 454(1):486-95. PubMed ID: 23792465
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study.
Aroui S; Brahim S; Waard MD; Kenani A
Biochem Biophys Res Commun; 2010 Jan; 391(1):419-25. PubMed ID: 19914216
[TBL] [Abstract][Full Text] [Related]
5. 15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting.
Ye J; Shin MC; Liang Q; He H; Yang VC
J Control Release; 2015 May; 205():58-69. PubMed ID: 25483423
[TBL] [Abstract][Full Text] [Related]
6.
Dong Y; Du P; Liu P
Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro evaluation of pH-sensitive PEG-I-dC16 block polymer micelles for anticancer drug delivery.
Rongbin H; Lei X; Ying L; Xiangping D; Xuan C; Lanfang L; Cuiyun Y; Yanming C; Guotao T
J Pharm Pharmacol; 2016 Jun; 68(6):751-61. PubMed ID: 27018539
[TBL] [Abstract][Full Text] [Related]
8. Protease-Responsive Prodrug with Aggregation-Induced Emission Probe for Controlled Drug Delivery and Drug Release Tracking in Living Cells.
Cheng Y; Huang F; Min X; Gao P; Zhang T; Li X; Liu B; Hong Y; Lou X; Xia F
Anal Chem; 2016 Sep; 88(17):8913-9. PubMed ID: 27503607
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro stability, and antiproliferative effect of d-cysteine modified GnRH-doxorubicin conjugates.
Li S; Zhao H; Chang X; Wang J; Zhao E; Yin Z; Mao X; Deng S; Hao T; Wang H; Yang Y
J Pept Sci; 2019 Jan; 25(1):e3135. PubMed ID: 30467919
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy.
Anbharasi V; Cao N; Feng SS
J Biomed Mater Res A; 2010 Sep; 94(3):730-43. PubMed ID: 20225211
[TBL] [Abstract][Full Text] [Related]
11. Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs.
Nasrolahi Shirazi A; Tiwari R; Chhikara BS; Mandal D; Parang K
Mol Pharm; 2013 Feb; 10(2):488-99. PubMed ID: 23301519
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cellular entry and efficacy of tat conjugates by rational design of the auxiliary segment.
Zhang P; Lock LL; Cheetham AG; Cui H
Mol Pharm; 2014 Mar; 11(3):964-73. PubMed ID: 24437690
[TBL] [Abstract][Full Text] [Related]
13. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.
Chavanpatil MD; Khdair A; Panyam J
Pharm Res; 2007 Apr; 24(4):803-10. PubMed ID: 17318416
[TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein peptide-combined DNA nanocomplex as an efficient anticancer drug delivery vehicle.
Zhang N; Tao J; Hua H; Sun P; Zhao Y
Eur J Pharm Biopharm; 2015 Aug; 94():20-9. PubMed ID: 25960329
[TBL] [Abstract][Full Text] [Related]
15. Design and Development of Polysaccharide-Doxorubicin-Peptide Bioconjugates for Dual Synergistic Effects of Integrin-Targeted and Cell-Penetrating Peptides for Cancer Chemotherapy.
Mansur AAP; Carvalho SM; Lobato ZIP; Leite MF; Cunha ADS; Mansur HS
Bioconjug Chem; 2018 Jun; 29(6):1973-2000. PubMed ID: 29790738
[TBL] [Abstract][Full Text] [Related]
16. Systematic research of peptide spacers controlling drug release from macromolecular prodrug system, carboxymethyldextran polyalcohol-peptide-drug conjugates.
Shiose Y; Kuga H; Ohki H; Ikeda M; Yamashita F; Hashida M
Bioconjug Chem; 2009 Jan; 20(1):60-70. PubMed ID: 19090781
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin B-Cleavable Cyclopeptidic Chemotherapeutic Prodrugs.
Herceg V; Bouilloux J; Janikowska K; Allémann E; Lange N
Molecules; 2020 Sep; 25(18):. PubMed ID: 32962018
[TBL] [Abstract][Full Text] [Related]
18. Cellular delivery of doxorubicin mediated by disulfide reduction of a peptide-dendrimer bioconjugate.
Burns KE; Delehanty JB
Int J Pharm; 2018 Jul; 545(1-2):64-73. PubMed ID: 29709616
[TBL] [Abstract][Full Text] [Related]
19. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
[TBL] [Abstract][Full Text] [Related]
20. Levofloxacin and indolicidin for combination antimicrobial therapy.
Ghaffar KA; Hussein WM; Khalil ZG; Capon RJ; Skwarczynski M; Toth I
Curr Drug Deliv; 2015; 12(1):108-14. PubMed ID: 25213074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
